Primary prevention implantable cardioverter defibrillators in women: More questions than answers.


The groundbreaking randomized trials of ICDs in the 1990s and 2000s were underpowered to assess risks and benefits of implantable cardioverter defibrillators (ICDs) in women. However, the overall survival benefit of primary prevention ICDs demonstrated in these trials was profound, so recommendations for the application of ICDs have not differed for men and… (More)
DOI: 10.1016/j.ahj.2015.04.005


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.